Biotech companies are showing leadership in early detection of cancer. March 16, 2021 Melanie Schaffer , Benzinga Staff Writer In January, Exact Sciences Corporation EXAS 1.59% announced it completed its acquisition of Thrive Earlier Detection Corp. and got Thrive’s blood-based multi-cancer detection technology. Why It Matters: Early detection of cancer greatly increases the survival rate and smaller biotech companies are showing leadership skills in […]
© 2021 BioMark Diagnostics Inc. All Rights Reserved. BioMark’s mission is to provide universal access to a new paradigm in cancer diagnostics using metabolomics.